We are live on
!
Find out more
ESPR
Esperion Therapeutics
ESPR
ESPR
Delisted
ESPR was delisted on the 10th of July, 2026.
188 hedge funds and large institutions have $286M invested in Esperion Therapeutics in 2025 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 56 increasing their positions, 37 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
196% more capital invested
Capital invested by funds: $96.6M → $286M (+$189M)
140% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 20
51% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 37
15% more funds holding
Funds holding: 163 → 188 (+25)
4% more ownership
Funds ownership: 49.55% → 53.55% (+4%)
9% more call options, than puts
Call options by funds: $3.25M | Put options by funds: $2.99M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
188
Holders Change
+25
Holders Change %
+15.34%
% of All Funds
2.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
48
Increased
56
Reduced
37
Closed
20
Calls
$3.25M
Puts
$2.99M
Net Calls
+$257K
Net Calls Change
+$783K
Top Buyers
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
+$6.36M |
| 2 |
Morgan Stanley
New York
|
+$5.8M |
| 3 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$5.8M |
| 4 |
RA
Royce & Associates
New York
|
+$4.44M |
| 5 |
IHAM
Integral Health Asset Management
New York
|
+$2.9M |
Top Sellers
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$6.34M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$5.4M |
| 3 |
ICM
Indaba Capital Management
San Francisco,
California
|
-$2.95M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$2.17M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.54M |
